FDA issues a warning to Amazon.com regarding its distribution of products that violate the federal Food, Drug, and Cosmetic Act.
- FDA purchased products on Amazon site labeled as energy-enhancing supplements or food, says laboratory analyses confirmed that they contained undeclared and potentially harmful active pharmaceutical ingredients
- Letter to CEO Andrew Jassy dated Dec. 20 seeks a response within 15 working days of its receipt
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
© ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.